Reporting Standards for Patient-Reported Outcomes in Clinical Trial Protocols and Publications
نویسندگان
چکیده
منابع مشابه
Standards for Reporting Qualitative Research
سخن سردبیر Editorial مجله دانشگاه علوم پزشکی رفسنجان دوره هجدهم، آذر 1398، 860-859 استاندارد‌هایی برای گزارش پژوهشهای کیفی Standards for Reporting Qualitative Research محسن رضائیان[1] M. Rezaeian تاکنون در مجله علمی دانشگاه، مقالات گوناگونی در خصوص استاندارد‌های تدوین شده برای گزارش شفاف پژوهشهای کمّی و از جمله کارآزمایی‌‌های بالینی [1] و مطالعات مشاهده‌ای اپیدمیو...
متن کاملPatient reported outcomes and patient empowerment in clinical genetics services.
Evaluation of clinical genetics services (CGS), including genetic counseling and genetic testing, has been problematic. Patient mortality and morbidity are unlikely to be directly improved by interventions offered in CGS. Patient-reported outcomes (PROs) are not routinely measured in CGS evaluation, but this may change as patient-reported outcome measures (PROMs) become a key part of how health...
متن کاملPatient-reported outcomes (PROs): the significance of using humanistic measures in clinical trial and clinical practice.
Patient-reported outcome (PRO) is an "umbrella term" that covers a whole range of potential types of measurement but it is used specifically to refer to all measures quantifying the state of health through the evaluation of outcomes reported by the patient himself/herself. PROs are increasingly seen as complementary to biomedical measures and they are being incorporated more frequently into cli...
متن کاملPatient-reported outcomes in clinical practice: using standards to break down barriers
While it seems obvious that medical care has always focused on the patient, recent efforts have been directed at formally integrating the patient’s ‘voice’ into clinical care. One of the main approaches for incorporating patient perspectives in clinical practice is the use of patient-reported outcomes (PROs) [1–3]. PROs are defined by the US FDA as “any report of the status of a patient’s healt...
متن کاملPatient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.
OBJECTIVES Neurofibromatosis (NF) is a genetic disease with multiple clinical manifestations that can significantly impact quality of life (QOL). Clinical trials should include patient-reported outcomes (PROs) as endpoints to assess treatment effects on various aspects of QOL, but there is no consensus on the selection and use of such measures in NF. This article describes the PRO Working Group...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI: Journal of the National Cancer Institute
سال: 2019
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/djz047